COMMUNIQUÉS West-GlobeNewswire

Genocea to Present at the Cowen & Company 39th Annual Health Care Conference
06/03/2019
CAMBRIDGE, Mass., March 06, 2019 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing personalized cancer immunotherapies, today announced that Chip Clark, president and [...]
Galectin Therapeutics Releases Richard E. Uihlein’s Open Letter to Stockholders
06/03/2019
NORCROSS, Ga., March 06, 2019 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today released this open letter to stockholders written [...]
Galectin Therapeutics Files Registration Statement for Stockholder Rights Offering of Common Stock and Warrants
06/03/2019
Richard E. Uihlein, Board Chair, expresses interest in investing $20.0 million in the Rights Offering NORCROSS, Ga., March 06, 2019 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ: GALT), the leading developer of [...]
Arise Austin Medical Center and The Hospital at Westlake Medical Center select Allscripts Sunrise
06/03/2019
Texas organizations choose Allscripts Sunrise™ for robust EHR with a single patient record CHICAGO, March 06, 2019 (GLOBE NEWSWIRE) -- Arise Austin Medical Center, located in Austin, TX and The Hospital at Westlake [...]
Galectin Therapeutics Reports Fiscal 2018 Financial Results and Provides Business Update
06/03/2019
Planning for Phase 3 clinical trial (NASH-RX) nearing completion for GR-MD-02, the first drug to show positive results in a clinical trial in patients with compensated NASH cirrhosis NORCROSS, Ga., March 06, 2019 (GLOBE [...]
Bio-Path Announces Clinical Update to Interim Analysis of Phase 2 Prexigebersen Trial in Acute Myeloid Leukemia
06/03/2019
Interim Data Update from Phase 2 Study Demonstrates Meaningful Clinical Improvement with Excellent Patient Safety Profile Company Provides Clinical Development Plan with Pathways to Registration HOUSTON, March 06, 2019 [...]
Tabula Rasa HealthCare Appoints New Member to its Board of Directors
06/03/2019
Rear Admiral Pamela Schweitzer, PharmD Joins Board of Medication Safety Company MOORESTOWN, N.J., March 06, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC) , a healthcare technology company [...]
Dose Response of Beta-Blockers in Adrenergic Receptor Polymorphism Genotypes Paper Published in Circulation: Genomic and Precision Medicine
06/03/2019
WESTMINSTER, Colo., March 06, 2019 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted therapies for [...]
IRIDEX to Present at the 31st Annual Roth Conference
06/03/2019
MOUNTAIN VIEW, Calif., March 06, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company plans to present at the upcoming 31 st Annual Roth Conference in Orange County, CA. Management is [...]
CymaBay Announces Pricing of Public Offering of Common Stock
06/03/2019
NEWARK, Calif., March 06, 2019 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (Nasdaq: CBAY), a clinical-stage biopharmaceutical company focused on developing and providing access to innovative therapies for patients [...]
Immutep doses First Patient in TACTI-002 Phase II Trial
06/03/2019
The First Patient has been dosed at “START Madrid- FJD” in Spain Clinical trial sites are active and more will be activated and commence recruitment in coming months SYDNEY, Australia, March 06, 2019 (GLOBE NEWSWIRE [...]
Aptinyx to Present at Cowen and Company 39th Annual Health Care Conference
06/03/2019
EVANSTON, Ill., March 06, 2019 (GLOBE NEWSWIRE) -- Aptinyx Inc. (NASDAQ: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, [...]
Mersana Therapeutics to Present at the Cowen and Company 39th Annual Healthcare Conference
06/03/2019
CAMBRIDGE, Mass., March 06, 2019 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc., (NASDAQ:MRSN) a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates ( [...]
Foamix Pharmaceuticals to Present at the Cowen & Company 39th Annual Health Care Conference
06/03/2019
REHOVOT, Israel and BRIDGEWATER, N.J., March 06, 2019 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX), (“Foamix”), a clinical stage specialty pharmaceutical company focused on developing and [...]
Wave Life Sciences to Present at the Cowen 39th Annual Health Care Conference
06/03/2019
CAMBRIDGE, Mass., March 06, 2019 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (NASDAQ: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating [...]
Mesa Labs Announces Changes in The Composition of Its Board of Directors
06/03/2019
LAKEWOOD, Colo., March 06, 2019 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) has announced several changes to the composition of its Board of Directors (the “Board”). [...]
miRagen Therapeutics to Present a Corporate Overview at the 29th Annual Oppenheimer & Co. Healthcare Conference
06/03/2019
BOULDER, Colo., March 06, 2019 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, announced [...]
Catalyst Biosciences Announces Poster Presentation at the Association for Research in Vision and Ophthalmology Annual Meeting
06/03/2019
SOUTH SAN FRANCISCO, Calif., March 06, 2019 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology [...]
MyoKardia to Present at Cowen & Co. 39th Annual Health Care Conference
06/03/2019
SOUTH SAN FRANCISCO, Calif., March 06, 2019 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK), a clinical-stage biopharmaceutical company pioneering precision medicine for the treatment of serious cardiovascular [...]

Pages